When a nurse is monitoring for effects of cisplatin chemotherapy, which condition should raise concern for auditory dysfunction?

Cisplatin is a chemotherapy agent known for its potential ototoxicity, which means it can cause damage to the auditory system and lead to hearing loss. Monitoring auditory function is a crucial aspect of nursing care for patients receiving cisplatin. The correct answer, which involves the client developing hearing loss, is significant because it directly indicates a potential adverse reaction to the medication that requires further evaluation and possibly intervention.

If a patient reports hearing loss while undergoing treatment with cisplatin, it signals a need for the healthcare team to assess the extent of the impairment and, if necessary, implement measures such as audiology consultations or adjusting the chemotherapy regimen to minimize further risks.

In contrast, symptoms like bloating, nausea, or fatigue, while relevant to the overall assessment of the patient's condition, do not specifically relate to the risk of auditory dysfunction associated with cisplatin. Therefore, they are less critical in this particular context of monitoring for auditory side effects.